- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Simulations Plus Inc (SLP)
Simulations Plus Inc stock price live, this page displays NASDAQ SLP stock exchange data. View the SLP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Simulations Plus Inc real time stock price chart below.
What Is the Simulations Plus Inc Stock Price Today?
The Simulations Plus Inc stock price today is 16.82.
What Is the Stock Symbol for Simulations Plus Inc?
The stock symbol for Simulations Plus Inc is ""SLP.""
What Stock Exchange Does Simulations Plus Inc Trade On?
Simulations Plus Inc is listed and trades on the NASDAQ stock exchange.
Is Simulations Plus Inc a Good Stock to Buy?
Determining whether Simulations Plus Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SLP quote. (ISIN: US8292141053)
What Is the Simulations Plus Inc Stock Price Today?
The Simulations Plus Inc stock price today is 16.82.
What Is the Stock Symbol for Simulations Plus Inc?
The stock symbol for Simulations Plus Inc is ""SLP.""
What Stock Exchange Does Simulations Plus Inc Trade On?
Simulations Plus Inc is listed and trades on the NASDAQ stock exchange.
Is Simulations Plus Inc a Good Stock to Buy?
Determining whether Simulations Plus Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SLP quote. (ISIN: US8292141053)
16.82
-0.18(-1.06%)
Real-time Data·
Fair Value
An estimate of a Simulations Plus's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.74
17.32
52 wk Range
12.39
37.67
Earnings results expected in 7 days
1/2
Fair Value
An estimate of a Simulations Plus's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.7417.32
52 wk Range
12.3937.67
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SLP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Simulations Plus's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
23.00
Upside
+36.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Form 13G Simulations Plus Inc For: 30 October
- Investing.com
- Form 13G Simulations Plus Inc For: 30 October
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral
Simulations Plus Inc Company Profile
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.
Simulations Plus Inc SWOT Analysis
Software Resilience | Explore SLP's robust software segment, showcasing 8% organic growth and a 10% increase in average revenue per customer, highlighting its essential role in pharmaceuticals |
Service Sector Challenges | Delve into the headwinds facing SLP's service segment, including client-driven delays and a significant contract cancellation impacting revenue forecasts |
Strategic Positioning | Learn how SLP maintains a competitive edge with its comprehensive software suite, trading at a premium compared to competitors despite recent market challenges |
Future Prospects | Discover SLP's revised outlook, with analyst price targets ranging from $28 to $41 per share, and potential opportunities arising from evolving FDA regulations |
Simulations Plus Inc Earnings Call Summary for Q3/2025
- Simulations Plus reported Q3 2025 revenue of $20.4M (+10% YoY), with software revenue at $12.6M (+6%) and services at $7.8M (+17%), despite a $3.35 diluted EPS loss due to a non-cash impairment charge.
- Adjusted diluted EPS improved to $0.45 from $0.27 last year, while adjusted EBITDA reached $7.4M (37% of revenue), driving a 1.1% stock price increase to $16.32.
- The company is expanding AI capabilities with new product launches and implementing a strategic reorganization to enhance operational efficiency amid biopharma market headwinds.
- Management provided FY2025 revenue guidance of $76-80M with software comprising 55-60%, and projected modest improvement in FY2026 with adjusted EBITDA margins of 23-27%.
- CEO Shawn O'Connor emphasized commitment to leveraging AI technologies for innovation and growth, while acknowledging challenges from patent expirations, pricing pressures, and client consolidation.
Last Updated: 20/11/2025, 15:56
Read Full TranscriptCompare SLP to Peers and Sector
Metrics to compare | SLP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSLPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.4x | −0.6x | −0.6x | |
PEG Ratio | 0.01 | 0.08 | 0.00 | |
Price/Book | 2.8x | 1.4x | 2.6x | |
Price / LTM Sales | 4.2x | 1.6x | 3.3x | |
Upside (Analyst Target) | 32.4% | 52.9% | 43.6% | |
Fair Value Upside | Unlock | 24.4% | 5.6% | Unlock |
Analyst Ratings
4 Buy
3 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 23.00
(+36.74% Upside)
Earnings
Latest Release
Jul 15, 2025
EPS / Forecast
-3.35 / 0.25
Revenue / Forecast
20.36M / 21.84M
People Also Watch
FAQ
What Stock Exchange Does Simulations Plus Trade On?
Simulations Plus is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Simulations Plus?
The stock symbol for Simulations Plus is "SLP."
What Is the Simulations Plus Market Cap?
As of today, Simulations Plus market cap is 340.35M.
What Is Simulations Plus's Earnings Per Share (TTM)?
The Simulations Plus EPS (TTM) is -3.15.
When Is the Next Simulations Plus Earnings Date?
Simulations Plus will release its next earnings report on 30 Nov 2025.
From a Technical Analysis Perspective, Is SLP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Simulations Plus Stock Split?
Simulations Plus has split 2 times.
How Many Employees Does Simulations Plus Have?
Simulations Plus has 245 employees.
What is the current trading status of Simulations Plus (SLP)?
As of 24 Nov 2025, Simulations Plus (SLP) is trading at a price of 16.82, with a previous close of 17.00. The stock has fluctuated within a day range of 16.74 to 17.32, while its 52-week range spans from 12.39 to 37.67.
What Is Simulations Plus (SLP) Price Target According to Analysts?
The average 12-month price target for Simulations Plus is USD23, with a high estimate of USD31 and a low estimate of USD16. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +36.74% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.